Post-prandial glucose changes in mild diabetic patient with clinical effect for EquMet (vildagliptin and metformin)

Arakawa T, Ogawa H, Bando H, Nagahiro S, Nakanishi M and Watanabe W

Published on: 2023-07-16

Abstract

This case is 74-year-old male with mild type 2 diabetes (T2D). HbA1c level kept 6.5-6.9% for recent several years, and took no oral hypoglycemic agents (OHAs). He likes to take delicious food of carbohydrate, and his post-prandial blood glucose levels usually increased to more than 200 mg/dL in 3 meals a day. He showed remarkable arterial stiffness, which may be from legacy effect of glucose variability. Providing vildagliptin and metformin (EquMet) has brought diabetic improvement for HbA1c 7.3% to 6.1%. Meal tolerance test (MTT) showed post-prandial hyperglycemia for 3 hours, in which prolonged glucose elevation was found after lunch.